학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 95건 | 목록 1~20
Academic Journal
The New England Journal of Medicine, 391, 18, pp. 1696-1708
Academic Journal
Bloem, M, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Blokx, W A M, Boers-Sonderen, M J, Bonenkamp, J J, de Groot, J W B, Haanen, J B, Hospers, G A P, Kapiteijn, E W, de Meza, M M, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, van den Eertwegh, A J M, Suijkerbuijk, K P M & Wouters, M W J M 2024, 'Adjuvant treatment with anti-PD-1 in acral melanoma : A nationwide study', International Journal of Cancer, vol. 155, no. 8, pp. 1455-1465. https://doi.org/10.1002/ijc.35060
International Journal of Cancer, 155, 8, pp. 1455-1465
Academic Journal
van Duin, I A J, Verheijden, R J, van Diest, P J, Blokx, W A M, el-Sharouni, M-A, Verhoeff, J J C, Leiner, T, van den Eertwegh, A J M, de Groot, J W B, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Haanen, J B A G, Hospers, G A P, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Stevense-den Boer, M A M, Boers-Sonderen, M J, Kapiteijn, E, Suijkerbuijk, K P M & Elias, S G 2024, 'A prediction model for response to immune checkpoint inhibition in advanced melanoma', International Journal of Cancer, vol. 154, no. 10, pp. 1760-1771. https://doi.org/10.1002/ijc.34853
International Journal of Cancer, 154, 10, pp. 1760-1771
Academic Journal
van Not, O J, van den Eertwegh, A J M, Haanen, J B, van Rijn, R S, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, de Groot, J W W B, Hospers, G A P, Kapiteijn, E, Bloem, M, Piersma, D, Stevense-den Boer, M, Verheijden, R J, van der Veldt, A A M, Wouters, M W J M, Blokx, W A M & Suijkerbuijk, K P M 2024, 'BRAF/MEK inhibitor rechallenge in advanced melanoma patients', Cancer, vol. 130, no. 9, pp. 1673-1683. https://doi.org/10.1002/cncr.35178
Cancer, 130, 9, pp. 1673-1683
Academic Journal
de Meza, M M, Blokx, W A M, Bonenkamp, H J, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J W B, Haanen, J B, Hospers, G A P, Kapiteijn, E W, van Not, O J, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, van den Eertwegh, A J M, Suijkerbuijk, K P M & Wouters, M W J M 2023, 'Adjuvant treatment of in-transit melanoma : Narrowing the knowledge gap left by clinical trials', International Journal of Cancer, vol. 153, no. 2, pp. 389-398. https://doi.org/10.1002/ijc.34485
International Journal of Cancer, 153, 2, pp. 389-398
Academic Journal
van Duin, I A J, Elias, S G, van den Eertwegh, A J M, de Groot, J W B, Blokx, W A M, van Diest, P J, Leiner, T, Verhoeff, J J C, Verheijden, R J, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Haanen, J B A G, Hospers, G A P, Kamphuis, A M, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Stevense-den Boer, M A M, Boers-Sonderen, M J, Kapiteijn, E & Suijkerbuijk, K P M 2023, 'Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma', International Journal of Cancer, vol. 152, no. 12, pp. 2493-2502. https://doi.org/10.1002/ijc.34479
International Journal of Cancer, 152, 12, pp. 2493-2502
Academic Journal
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, 'Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125. https://doi.org/10.1056/NEJMoa2210233
The New England Journal of Medicine, 387, 23, pp. 2113-2125
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, ' Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma. ', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125 . https://doi.org/10.1056/NEJMoa2210233
Academic Journal
van Breeschoten, J, Ismail, R K, Wouters, M W J M, Hilarius, D L, de Wreede, L C, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Suijkerbuijk, K P M & van den Eertwegh, A J M 2022, 'End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma : A Nationwide Cohort Study', JCO oncology practice, vol. 18, no. 10, pp. e1611-e1620. https://doi.org/10.1200/OP.22.00061
JCO Oncology Practice, 18, 10, pp. e1611-e1620
Academic Journal
Int J Cancer
van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, 'The unfavorable effects of COVID-19 on Dutch advanced melanoma care', International Journal of Cancer, vol. 150, no. 5, pp. 816-824. https://doi.org/10.1002/ijc.33833
International Journal of Cancer, 150, 5, pp. 816-824
검색 결과 제한하기
제한된 항목
[검색어] Stevense-den Boer, Marion
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어